Denali Therapeutics DNLI
NASDAQ DNLI
$18.68 -0.25 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Receivables - Other (2020 - 2022)

Updated

Denali Therapeutics (DNLI) posted Receivables - Other of $357,000 for Q2 2022, down 77.2% from $1.57 million a year earlier.

Analysis

Denali Therapeutics (DNLI) Receivables - Other (2020 - 2022) Analysis & Trends

At the end of FY2021, Denali Therapeutics' Receivables - Other came in at $1.23 million, down 78.4% from FY2020.

  • In prior years, Denali Therapeutics' Receivables - Other was $5.67 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Denali Therapeutics 3.51 Bn 96.04 Mn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 357,000.00
Dec 31, 2021 1.23 Mn
Sep 30, 2021 1.19 Mn
Jun 30, 2021 1.57 Mn
Mar 31, 2021 2.51 Mn
Dec 31, 2020 5.67 Mn
API Access

Denali Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=DNLI&period=max&api_key=YOUR_API_KEY